Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion type Assertion NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_head.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion description "[Furthermore, romidepsin induces expression of genes such as p21 and expression of p75 and NTRK (TrkA) which are more highly expressed in the tumors from NB patients that have a good prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_provenance.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion evidence source_evidence_literature NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_provenance.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion SIO_000772 20404560 NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_provenance.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion wasDerivedFrom befree-2016 NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_provenance.
- NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_assertion wasGeneratedBy ECO_0000203 NP807014.RAl72f7f4b0-MLpYNzLw8cneBEtg86k8hv4iCQcqFV3MU130_provenance.